Hoeper MM, Humbert M, Souza R, Idrees M, Kawut SM, Sliwa-Hahnle K, Jing Z-C, Gibbs JSR (2016) A global view of pulmonary hypertension. Lancet Respir Med 4:306–322

PubMed  Google Scholar 

Minai OA, Chaouat A, Adnot S (2010) Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest 137:39S-51S

PubMed  Google Scholar 

Zhang L, Liu Y, Zhao S et al (2022) The incidence and prevalence of pulmonary hypertension in the COPD population: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis 17:1365–1379

PubMed  PubMed Central  Google Scholar 

Shlobin OA, Adir Y, Barbera JA, Cottin V, Harari S, Jutant E-M, Pepke-Zaba J, Ghofrani H-A, Channick R (2024) Pulmonary hypertension associated with lung diseases. Eur Respir J. https://doi.org/10.1183/13993003.01200-2024

Article  PubMed  PubMed Central  Google Scholar 

Steger M, Canuet M, Martin G et al (2024) Pulmonary hypertension associated with COPD: a phenotype analysis. ERJ Open Res. https://doi.org/10.1183/23120541.00716-2024

Article  Google Scholar 

Weatherald J, Hemnes AR, Maron BA, Mielniczuk LM, Gerges C, Price LC, Hoeper MM, Humbert M (2024) Phenotypes in pulmonary hypertension. Eur Respir J. https://doi.org/10.1183/13993003.01633-2023

Article  PubMed  PubMed Central  Google Scholar 

Zeder K, Avian A, Bachmaier G et al (2021) Elevated pulmonary vascular resistance predicts mortality in COPD patients. Eur Respir J. https://doi.org/10.1183/13993003.00944-2021

Article  PubMed  Google Scholar 

Humbert M, Kovacs G, Hoeper MM et al (2022) 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. https://doi.org/10.1183/13993003.00879-2022

Article  PubMed  PubMed Central  Google Scholar 

Myronenko O, Foris V, Crnkovic S, Olschewski A, Rocha S, Nicolls MR, Olschewski H (2023) Endotyping COPD: hypoxia-inducible factor-2 as a molecular “switch” between the vascular and airway phenotypes? Eur Respir Rev. https://doi.org/10.1183/16000617.0173-2022

Article  PubMed  PubMed Central  Google Scholar 

Pasupneti S, Tian W, Tu AB et al (2020) Endothelial HIF-2α as a key endogenous mediator preventing emphysema. Am J Respir Crit Care Med 202:983–995

CAS  PubMed  PubMed Central  Google Scholar 

Patel SA, Simon MC (2008) Biology of hypoxia-inducible factor-2α in development and disease. Cell Death Differ 15:628–634

CAS  PubMed  Google Scholar 

Silverberg DS, Mor R, Weu MT, Schwartz D, Schwartz IF, Chernin G (2014) Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron. BMC Pulm Med 14:24

PubMed  PubMed Central  Google Scholar 

Tatah J, Keen JL, Prisco SZ, Pritzker M, Thenappan T, Prins KW (2022) Iron deficiency is associated with more severe pulmonary vascular disease in pulmonary hypertension caused by chronic lung disease. Chest 161:232–236

CAS  PubMed  Google Scholar 

Savarese G, von Haehling S, Butler J, Cleland JGF, Ponikowski P, Anker SD (2023) Iron deficiency and cardiovascular disease. Eur Heart J 44:14–27

CAS  PubMed  Google Scholar 

Najafinobar N, Venkatesan S, von Sydow L, Klarqvist M, Olsson H, Zhou X-H, Cloonan SM, Malmberg P (2019) ToF-SIMS mediated analysis of human lung tissue reveals increased iron deposition in COPD (GOLD IV) patients. Sci Rep 9:10060

PubMed  PubMed Central  Google Scholar 

Martens P, Yu S, Larive B et al (2023) Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications. Eur Heart J 44:1979–1991

CAS  PubMed  PubMed Central  Google Scholar 

Harms K, Kaiser T (2015) Beyond soluble transferrin receptor: old challenges and new horizons. Best Pract Res Clin Endocrinol Metab 29:799–810

CAS  PubMed  Google Scholar 

Kang M, Kwon S, Lee W et al (2022) Soluble transferrin receptor can predict all-cause mortality regardless of anaemia and iron storage status. Sci Rep 12:11911

CAS  PubMed  PubMed Central  Google Scholar 

Deng Y-T, You J, He Y et al (2025) Atlas of the plasma proteome in health and disease in 53026 adults. Cell 188:253-271.e7

CAS  PubMed  Google Scholar 

Hoffmann J, Wilhelm J, Marsh LM, Ghanim B, Klepetko W, Kovacs G, Olschewski H, Olschewski A, Kwapiszewska G (2014) Distinct differences in gene expression patterns in pulmonary arteries of patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis with pulmonary hypertension. Am J Respir Crit Care Med 190:98–111

CAS  PubMed  Google Scholar 

Kondo K, Noguchi M, Mukai K, Matsuno Y, Sato Y, Shimosato Y, Monden Y (1990) Transferrin receptor expression in adenocarcinoma of the lung as a histopathologic indicator of prognosis. Chest 97:1367–1371

CAS  PubMed  Google Scholar 

Bankhead P, Loughrey MB, Fernández JA et al (2017) QuPath: op en source software for digital pathology image analysis. Sci Rep 7:16878

PubMed  PubMed Central  Google Scholar 

Hampole CV, Mehrotra AK, Thenappan T, Gomberg-Maitland M, Shah SJ (2009) Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension†. Am J Cardiol 104:868–872

CAS  PubMed  Google Scholar 

Yang J, Liu C, Li L, Tu X, Lu Z (2019) Red blood cell distribution width predicts pulmonary hypertension sary to chronic obstructive pulmonary disease. Can Respir J 2019:e3853454

Google Scholar 

Gredic M, Blanco I, Kovacs G, Helyes Z, Ferdinandy P, Olschewski H, Barberà JA, Weissmann N (2021) Pulmonary hypertension in chronic obstructive pulmonary disease. Br J Pharmacol 178:132–151

CAS  PubMed  Google Scholar 

Humbert M, Sitbon O, Guignabert C, Savale L, Boucly A, Gallant-Dewavrin M, McLaughlin V, Hoeper MM, Weatherald J (2023) Treatment of pulmonary arterial hypertension: recent progress and a look to the future. Lancet Respir Med 11:804–819

PubMed  Google Scholar 

Kovacs G, Avian A, Bachmaier G et al (2022) Severe pulmonary hypertension in COPD: impact on survival and diagnostic approach. Chest 162:202–212

PubMed  PubMed Central  Google Scholar 

Foris V, Kovacs G, Tscherner M, Olschewski A, Olschewski H (2013) Biomarkers in pulmonary hypertension: what do we know? Chest 144:274–283s

CAS  PubMed  Google Scholar 

Leung JM, Obeidat M, Sadatsafavi M, Sin DD (2019) Introduction to precision medicine in COPD. Eur Respir J 53:1802460

PubMed  Google Scholar 

Galy B, Conrad M, Muckenthaler M (2024) Mechanisms controlling cellular and systemic iron homeostasis. Nat Rev Mol Cell Biol 25:133–155

CAS  PubMed  Google Scholar 

Beguin Y (2003) Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 329:9–22

CAS  PubMed  Google Scholar 

Sato K, Inoue S, Igarashi A et al (2020) Effect of iron deficiency on a murine model of smoke-induced emphysema. Am J Respir Cell Mol Biol 62:588–597

CAS  PubMed  Google Scholar 

Cotroneo E, Ashek A, Wang L, Wharton J, Dubois O, Bozorgi S, Busbridge M, Alavian KN, Wilkins MR, Zhao L (2015) Iron homeostasis and pulmonary hypertension. Circ Res 116:1680–1690

CAS  PubMed  Google Scholar 

Bertoli SR, Marques VB, Rossi EM, Krause M, Carneiro MTWD, Simões MR, dos Santos L (2018) Chronic iron overload induces vascular dysfunction in resistance pulmonary arteries associated with right ventricular remodeling in rats. Toxicol Lett 295:296–306

CAS  PubMed  Google Scholar 

Smith TG, Talbot NP, Privat C, Rivera-Ch M, Nickol AH, Ratcliffe PJ, Dorrington KL, León-Velarde F, Robbins PA (2009) Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. JAMA 302:1444

CAS  PubMed  Google Scholar 

Hartmann JP, Bailey DM, Berg RMG (2023) A song of iron and oxygen: hypoxic pulmonary vasoconstriction and gas exchange in chronic obstructive pulmonary disease. Exp Physiol 108:535–538

PubMed  PubMed Central  Google Scholar 

Naito Y, Hosokawa M, Sawada H et al (2016) Transferrin receptor 1 in chronic hypoxia-induced pulmonary vascular remodeling. Am J Hypertens 29:713–718

CAS